Like everyone who works in transplant medicine, Liise Kayler is keenly aware of the challenges and cruel ironies that plague kidney transplantation in general.
Allison Brashear, MD, vice president for health sciences and dean of the Jacobs School, is recruiting patients for the NIH-funded study she is leading on people with ATP1A3 disorders.
On Feb. 28, the Jacobs School will hold a virtual event to recognize rare disease patients, their clinicians and the researchers working to discover the causes of these conditions and, ultimately, the cures.